Canadian 2003 international consensus algorithm for the diagnosis, therapy, and management of hereditary angioedema
C1 inhibitor deficiency (hereditary angioedema [HAE]) is a rare disorder for which there is a
lack of consensus concerning diagnosis, therapy, and management, particularly in Canada …
lack of consensus concerning diagnosis, therapy, and management, particularly in Canada …
2010 International consensus algorithm for the diagnosis, therapy and management of hereditary angioedema
Abstract Background We published the Canadian 2003 International Consensus Algorithm
for the Diagnosis, Therapy, and Management of Hereditary Angioedema (HAE; C1 inhibitor …
for the Diagnosis, Therapy, and Management of Hereditary Angioedema (HAE; C1 inhibitor …
Hereditary angiodema: a current state-of-the-art review, VII: Canadian Hungarian 2007 International Consensus Algorithm for the Diagnosis, Therapy, and …
BACKGROUND: We published the Canadian 2003 International Consensus Algorithm for
the Diagnosis, Therapy, and Management of Hereditary Angioedema (HAE; C1 inhibitor [C1 …
the Diagnosis, Therapy, and Management of Hereditary Angioedema (HAE; C1 inhibitor [C1 …
WAO guideline for the management of hereditary angioedema
T Craig, EA Pürsün, K Bork, T Bowen, H Boysen… - World Allergy …, 2012 - Springer
Hereditary Angioedema (HAE) is a rare disease and for this reason proper diagnosis and
appropriate therapy are often unknown or not available for physicians and other health care …
appropriate therapy are often unknown or not available for physicians and other health care …
[HTML][HTML] Consensus on treatment goals in hereditary angioedema: a global Delphi initiative
Background Hereditary angioedema (HAE) is a rare, life-threatening genetic disorder
characterized by recurrent episodes of subcutaneous or submucosal angioedema. The …
characterized by recurrent episodes of subcutaneous or submucosal angioedema. The …
Canadian hereditary angioedema guideline
S Betschel, J Badiou, K Binkley, J Hébert… - Allergy, Asthma & …, 2014 - Springer
Hereditary angioedema (HAE) is a disease which is associated with random and often
unpredictable attacks of painful swelling typically affecting the extremities, bowel mucosa …
unpredictable attacks of painful swelling typically affecting the extremities, bowel mucosa …
US Hereditary Angioedema Association Medical Advisory Board 2013 recommendations for the management of hereditary angioedema due to C1 inhibitor deficiency
Background The treatment of hereditary angioedema (HAE) has undergone dramatic
changes as newer medicines have become available in recent years. Optimal care of these …
changes as newer medicines have become available in recent years. Optimal care of these …
[HTML][HTML] International consensus on hereditary and acquired angioedema
DM Lang, W Aberer, JA Bernstein, HH Chng… - Annals of Allergy …, 2012 - Elsevier
In light of the remarkable progress recently achieved in our understanding of angioedema,
the American Academy of Allergy, Asthma and Immunology, American College of Allergy …
the American Academy of Allergy, Asthma and Immunology, American College of Allergy …
The International/Canadian hereditary angioedema guideline
S Betschel, J Badiou, K Binkley, R Borici-Mazi… - Allergy, Asthma & …, 2019 - Springer
This is an update to the 2014 Canadian Hereditary Angioedema Guideline with an
expanded scope to include the management of hereditary angioedema (HAE) patients …
expanded scope to include the management of hereditary angioedema (HAE) patients …
Hereditary angioedema with C1 inhibitor deficiency: delay in diagnosis in Europe
A Zanichelli, M Magerl, H Longhurst, V Fabien… - Allergy, Asthma & …, 2013 - Springer
Background Hereditary angioedema (HAE) is a rare, debilitating, and potentially life-
threatening disease characterized by recurrent edema attacks. Important advances in HAE …
threatening disease characterized by recurrent edema attacks. Important advances in HAE …